Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood
NCT02533895
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Childhood Solid Tumor
Interventions
BIOLOGICAL:
AV0113 DC-CIT
OTHER:
Data evaluation
Sponsor
Activartis Biotech